Tuesday, December 23, 2014 11:19:19 AM
LOS ANGELES, Dec. 2. 2014 /PRNewswire/ -- Migranade, Inc., the maker of MIGRANADE Migraine Relief, announced today that it has created a new division devoted to the development and marketing of a line of therapeutic homeopathic nasal sprays.
"The recent acquisition of Oasis Health Products accelerates the company's ability to formulate, test and manufacture new homeopathic nasal spray formulations," said a company spokesperson. "Our first product will be a nasal spray version of MIGRANADE Migraine Relief. This homeopathic nasal spray will allow migraine sufferers to have immediate access to the medicine while away from home."
The nasal spray is expected to hit the market in the first quarter of 2015. MIGRANADE Migraine Relief is available at http://www.migranade.com and will soon hit the major retail chains.
ABOUT MIGRANADE, INC.
Migranade, Inc. is a U.S. Pharmaceutical company with a focus on the research and development, manufacturing and marketing of medications for the treatment and prevention of migraine headache. MIGRANADE Migraine Relief is a proprietary oral effervescent medication for the treatment of migraine headaches. MIGRANADE Migraine Relief targets the actual cause of the migraine headaches vs. only treating symptoms. For media inquiries contact Orange County, CA Public Relations Agency www.drivenpublicrelations.com or send an email to info@migranade.com
ABOUT OASIS HEALTH PRODUCTS, INC.
Oasis Health Products, an FDA inspected, GMP facility, is one of the few manufacturers capable of producing high quality homeopathic medicines. Oasis provides formula & product development and manufacturing, advice, guidance, and contacts in areas such as sales, distribution, logistics, marketing, warehousing, etc. For media inquiries contact Orange County, CA Public Relations Agency www.drivenpublicrelations.com or send an email to info@migranadeinc.com.
****NOTE I WENT TO OASIS PHARMA IN EARLY SEPT. & THE BUILDNING IS WORTH A MINIMUM OF $25 MILLION DOLLARS & IS ONLY 2 YEARS OLD.
MIGRANADE WILL EITHER
1. BUYOUT EMESYL PRODUCT,
2. DO A REVERSE MERGER INTO ITNS SO THEY CAN BECOME A PUBLIC TRADING COMPANY.
3. BUYOUT ITNS TOTALLY
IN ANY EVENT SOMETHING HUGE IS GOING ON HERE BETWEEN ITNS & MIGRANADE.
ONLY PATIENCE & TIME WILL UNVAIL THE FACTS.
BEST PLAY IN PENNYLAND FO0R THE RISK/REWARD OF A SMALL INVESTMENT THAT I KNOW OF!!!!!
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM